Antagonism of botulinum toxin-induced muscle weakness by 3,4-diaminopyridine in rat phrenic nerve-hemidiaphragm preparations

By Adler M.   Scovill J.   Parker G.   Lebeda F.J.   Piotrowski J.   Deshpande S.S.  

Toxicon, Vol. 33, Iss. 4, 1995-04 ,pp. : 527-537

Elsevier

Access to resources Recommend Favorite

Antagonism of botulinum toxin A-mediated muscle paralysis by 3,4-diaminopyridine delivered via osmotic minipumps

By Adler M.   Capacio B.   Deshpande S.S.  

Toxicon, Vol. 38, Iss. 10, 2000-10 ,pp. : 1381-1388

Elsevier

Access to resources Recommend Favorite

The structure and mechanism of action of botulinum toxin.

By Bakry N.   Coffield J.   Maksymowych A.B.   Zhang R.   Simpson L.L.  

Toxicon, Vol. 34, Iss. 3, 1996-03 ,pp. : 294-294

Elsevier

Access to resources Recommend Favorite

Pharmacologic characterization of botulinum toxin for basic science and medicine

By Pearce L.B.   First E.R.   MacCallum R.D.   Gupta A.  

Toxicon, Vol. 35, Iss. 9, 1997-09 ,pp. : 1373-1412

Elsevier

Access to resources Recommend Favorite

Therapeutic botulinum type A toxin: factors affecting potency

By McLellan K.   Das R.E.G.   Ekong T.A.N.   Sesardic D.  

Toxicon, Vol. 34, Iss. 9, 1996-09 ,pp. : 975-985

Elsevier

Access to resources Recommend Favorite